Medication info
Crevaget 10/5 mg Tablet

Crevaget 10/5 mg Tablet

Prescription medicationTabletOral
Ingredient · strength
Rosuvastatin Calcium›5.2mg / 1 tabletEzetimibe›10mg / 1 tablet
Manufacturer / importer
Youngil Pharmaceutical Co., Ltd.
Appearance
Pink, oblong film-coated tablets
Packaging
30 tablets/box [10 tablets/PTP x 3]
Approval status
Active

MFDS item code 202004608 · Approved 2020.06.23 · Insurance code 649405530

Summary

Main use
For the treatment of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
This medicine is administered once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response to treatment. Primary hypercholesterolemia The dose range is 10/5mg to 10/20mg once daily. The recommended starting dose is 10/5mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting treatment or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose adjusted accordingly. The dose may be increased to a maximum of 10/20mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.

Ingredients

Manufacturer
Youngil Pharmaceutical Co., Ltd.

Efficacy & effects

For the treatment of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL-cholesterol
  • elevated Apo B protein
  • elevated triglycerides
  • elevated non-HDL cholesterol
  • increased risk of atherosclerotic vascular diseases
  • dyslipidemia
  • diabetes
View approved original text

This drug helps lower total cholesterol, LDL-cholesterol, Apo B protein, triglycerides, and non-HDL cholesterol levels in patients with primary hypercholesterolemia or mixed dyslipidemia, while increasing levels of HDL cholesterol, the good cholesterol. It is particularly used in conjunction with an appropriate diet when there is a risk of atherosclerotic vascular disease due to hypercholesterolemia. Before administration, it is important to identify and treat other causes of dyslipidemia, such as diabetes or hypothyroidism, if necessary. It is also necessary to accurately measure lipid levels to determine the treatment direction, and lipid tests are recommended to be conducted early in hospitalization during acute coronary events. This drug is an effective treatment method to maintain healthy lipid levels and reduce the risk of cardiovascular diseases.

How to take

Adult dose

This medicine is administered once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response to treatment. Primary hypercholesterolemia The dose range is 10/5mg to 10/20mg once daily. The recommended starting dose is 10/5mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting treatment or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose adjusted accordingly. The dose may be increased to a maximum of 10/20mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.

Precautions

This drug can rarely cause a serious side effect called rhabdomyolysis, which could lead to acute renal failure. If serious muscle symptoms occur or if there are risk factors, administration should be discontinued or temporarily halted. Additionally, this drug can affect liver function and should not be used if there is liver disease or elevated liver enzyme levels. Patients at high risk for myopathy or rhabdomyolysis should have blood tests to check muscle enzyme levels before administration, and continuous monitoring is required during treatment. This drug should not be administered to pregnant women or nursing mothers, and women of childbearing potential should use appropriate contraception during treatment. It is safe not to use this drug in certain patient populations such as alcoholics, patients with severe renal failure, and those with muscle diseases. Interactions may occur when combined with other medications, so it is essential to inform healthcare professionals of any medications being taken. During treatment with this drug, immediately inform a doctor if symptoms such as muscle pain, muscle cramps, muscle weakness, fatigue, fever, etc. occur. If symptoms of liver dysfunction or severe skin reactions such as severe rashes or urticaria occur, stop taking the medication immediately and consult with healthcare professionals. Caution is advised when administering to children or the elderly, especially since the elderly have a higher risk of myopathy. In case of overdose, no specific antidote exists, so treatment should be symptomatic, and liver and muscle function tests should be performed. This drug contains lactose, so patients with lactose intolerance should avoid taking it. Finally, this drug should be stored out of the reach of children and should not be transferred to another container.

Side effects

Acute renal failure due to myoglobinuria, rhabdomyolysis, nasopharyngitis, dyspepsia, elevated ALT, edema, myalgia, elevated CPK, elevated AST, headache, acute pyelonephritis, dry mouth, liver enzyme elevation, abnormal liver function tests, increased serum lactate dehydrogenase, pruritus, upper respiratory tract infection, elevated blood glucose, chest discomfort, dizziness, drowsiness, neurodegenerative disorder, postural dizziness, migraine, diabetes, glucose tolerance disorder, depression, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue infection, hepatic steatosis, liver disorders, liver toxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, increased blood cholesterol, increased alkaline phosphatase, irregular heart rate, osteoarthritis, osteoporosis, musculoskeletal rigidity, musculoskeletal discomfort, muscle weakness, diaphoresis, dermatitis, skin burning, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory distress, pelvic pain, breast cysts, ptosis, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, chest pain, facial edema, unusual sensations, drug intolerance, irritable bowel syndrome, esophagitis, colon polyps, thrombocytopenia, polyneuropathy, amnesia, peripheral neuropathy, cough, dyspnea, diarrhea, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, eosinophilia and systemic symptoms associated with drug reaction syndrome, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, sleep disorders, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, memory decline, forgetfulness, amnesic syndrome, memory disorders, confusion, myasthenia gravis, ocular myasthenia, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myopathy, myositis, weakness, angioedema, increased blood glucose, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, fatigue, numbness, paresthesia, chest discomfort, anorexia, abdominal distension, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, tremors, epigastric pain, vomiting, gastritis, xerostomia, epigastric discomfort, belching, gastrointestinal disorder, gastroesophageal reflux disease, tongue disorders, urticaria, hyperhidrosis, rash, pruritus, upper respiratory tract infection, conjunctival hyperemia, renal failure, abnormal liver function, increased serum creatinine, elevated blood pressure, increased serum urea, increased CPK, abnormal liver function tests

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly sealed container to avoid exposure to air or moisture. Additionally, it should be kept at a cool room temperature, specifically between 1 to 30 degrees Celsius, to maintain its effectiveness.

Appearance and packaging

Appearance

Pink, oblong film-coated tablets

Package unit

30 tablets/box [10 tablets/PTP x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.